HOME >> BIOLOGY >> NEWS
International experts to say what's known, what's speculation about medicinal herbs

Are medicinal herbs -- now extremely popular in the United States but only poorly regulated -- safe? Do they work? Or are they just so much snake oil? How much should a person take to produce the desired effect?

Some of the world's top experts on the effects of garlic, ginseng, ginko biloba, comfrey, saw palmetto, feverfew, echinacea and St. John's wort will summarize what's known about the herbs and what remains speculation at an 11:45 a.m. news conference Thursday (March 2). Reporters are invited to the briefing, which will be held in the Dogwood Room of the University of North Carolina at Chapel Hill's William and Ida Friday Center for Continuing Education.

The event is part of the first international scientific conference on medicinal herbs, which continues through Friday (March 3) at the Friday Center. The unique gathering, which also will present new research findings, is being sponsored by the UNC Institute of Nutrition, the UNC-CH schools of medicine and public health, Duke University, the National Institute of Environmental Health Sciences and other organizations.

Television crews can unload equipment in front of the center, which is located just off N.C. 54 roughly midway between Interstate 40 and the UNC-CH campus. The access road is marked with brown signs along the highway.


'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
27-Feb-2000


Page: 1

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. 1st International Conference on Cell Therapy for Cardiovascular Disease
8. International research conferences at the Villa Vigoni
9. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
10. STN International launches Derwent World Patents Index First View
11. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/3/2017)... -- Onitor, provider of digital health technology for consumers, ... biometric data-driven program designed to aid weight loss for ... Consumer Electronics Show (CES) in Las Vegas ... World Health Organization (WHO), have identified lifestyle risks that ... overweight or obese. WHO also states that more people ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/16/2016)... , Dec. 16, 2016   IdentyTechSolutions America ... management products and solutions and a cutting-edge manufacturer ... that it is offering seamless, integrated solutions that ... entrance products. The solutions provide IdentyTech,s customers with ... their facilities from crime and theft. ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... Conn. , Jan. 12, 2017   ... company and maker of Flublok Influenza Vaccine ... Zika vaccine candidate had good safety results and ... in preclinical studies. The product is expected to ... few months.  In addition, the Institute of Technology ...
(Date:1/12/2017)... -- The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), ... - Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated ... USD 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical ... promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. ... Twenty-seven percent of these heavily pretreated patients saw clinical benefit from the drug, ...
(Date:1/11/2017)... ... 11, 2017 , ... As a graduate student, Scarlet Shell ... that cause malaria and tuberculosis. Seeing firsthand the ravages those diseases visit on ... an assistant professor of biology and biotechnology at Worcester Polytechnic Institute (WPI), Shell ...
Breaking Biology Technology:
Cached News: